Unique ID issued by UMIN | UMIN000020142 |
---|---|
Receipt number | R000023261 |
Scientific Title | CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to endoscopic retrograde cholangiopancreatography (post-ERCP pancreatitis) |
Date of disclosure of the study information | 2015/12/14 |
Last modified on | 2024/12/16 09:12:34 |
CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to endoscopic retrograde cholangiopancreatography (post-ERCP pancreatitis)
CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to post-ERCP pancreatitis
CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to endoscopic retrograde cholangiopancreatography (post-ERCP pancreatitis)
CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to post-ERCP pancreatitis
Japan |
Bile duct of pancreatic disease
Hepato-biliary-pancreatic medicine | Radiology |
Malignancy
NO
To detect the predictive factors of post-ERCP pancreatitis in CT perfusion findings after ERCP
Others
Image data analysis
Exploratory
Others
Not applicable
Blood volume of the pancreas after ERCP
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Scheduled ERCP for bile duct or pancreatic disease exam.
2) 20 years old of more.
3) Included in high risk group of post-ERCP pancreatitis (PEP) (meeting the following A or B)
(A) Meeting one or more of the following factors
i) Sphincter of Oddi dysfunction
ii) History of PEP
iii) Pancreatic sphincterotomy
iv) Pancreatic sphincter precutting (upward incision precut)
v) Difficult catheter insertion (10 min or more for cannulation, of 10 times or more of bile duct approach)
vi) Vater sphincterotomy
(B) Meeting two or more of the following factors.
i) 50 years old or less
ii) Womem
iii) History of pancreatitis
iv) Pancreatography or insertion of guide wire into the pancreatic duct
v) Papillary balloon dilatation
4) Written informed consent is obtained.
1) Absolute contraindication to iodinated contrast material
2) eGFR < 30mL/min/1.73m2
3) New York heart association classification: class III or IV.
4) Severe lung disfunction
5) Impossible to perform ERCP because of digestive tract stenosis or trismus
6) Eastern Cooperative Oncology Group performance status 4
7) Pregnant or lactating women
8) Excluded by study directors because of other considerable factor(s)
50
1st name | Masaki |
Middle name | |
Last name | Kuwatani |
Hokkaido Univesity Hospital
Department of Gastroenterology and Hepatology
0608648
W-5, N-14, KIta-ku, Sapporo
0117161161
mkuwatan@med.hokudai.ac.jp
1st name | Kuwatani |
Middle name | |
Last name | Masaki |
Hokkaido University Hospital
Department of Gastroenterology and Hepatology
0608648
W-5, N-14, KIta-ku, Sapporo
0117161161
mkuwatan@med.hokudai.ac.jp
Hokkaido University Hospital
Not applicable
Self funding
Clinical Research and Medical Innovation Center, Hokkaido University Hospital
W-5, N-14, KIta-ku, Sapporo
0117067636
crjimu@huhp.hokudai.ac.jp
NO
2015 | Year | 12 | Month | 14 | Day |
Unpublished
50
No longer recruiting
2015 | Year | 10 | Month | 28 | Day |
2015 | Year | 10 | Month | 28 | Day |
2015 | Year | 12 | Month | 14 | Day |
2022 | Year | 12 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
Prospective observational study
Patients who visit our hospital from October 2015 to December 2022 and meet the inclusion criteria
2015 | Year | 12 | Month | 10 | Day |
2024 | Year | 12 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023261